VanArsdale, Todd
Pfizer (United States)
3 papers on CoChatORCID 0009-0003-7692-623X
Most cited papers
- Verified
Spectrum and Degree of CDK Drug Interactions Predicts Clinical Performance
Chen, P., Lee, N. V., Hu, W., Xu, M., Ferre, R. A., Lam, H., Bergqvist, S., Solowiej, J., Diehl, W., He, Y.-A., et al. (2016) · Molecular Cancer Therapeutics
Advanced Breast Cancer TherapiesComputational Drug Discovery Methods
Cited by 444
- Verified
Molecular pathways: targeting the cyclin D-CDK4/6 axis for cancer treatment
VanArsdale, T., Boshoff, C., Arndt, K. T., & Abraham, R. T. (2015) · Clinical Cancer Research
Advanced Breast Cancer TherapiesCancer-related Molecular Pathways
Cited by 396
- Verified
A versatile drug delivery system targeting senescent cells
Muñoz‐Espín, D., Rovira, M., Galiana, I., Giménez, C., Lozano‐Torres, B., Paez‐Ribes, M., Llanos, S., Chaib, S., Muñoz‐Martín, M., Ucero, A. C., et al. (2018) · EMBO Molecular Medicine
Telomeres, Telomerase, and SenescenceNanoparticle-Based Drug Delivery
Cited by 339
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free